Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6,385 JPY | +1.09% | +1.69% | -18.25% |
May. 15 | Ibiden Co.,Ltd. Approves Year End Cash Dividends, Effective May 30, 2024 | CI |
Apr. 11 | Jefferies Starts Ibiden at Hold With 6,630 Yen Price Target | MT |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Analysts covering this company mostly recommend stock overweighting or purchase.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- The company benefits from high valuations in earnings multiples.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- Revenue estimates are regularly revised downwards for the current and coming years.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last few months, analysts have been revising downwards their earnings forecast.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Semiconductors
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-18.23% | 5.7B | B | ||
+135.11% | 2,861B | B- | ||
+41.48% | 672B | A- | ||
+19.22% | 617B | C | ||
+8.56% | 259B | B- | ||
+41.29% | 228B | B- | ||
+13.37% | 176B | A- | ||
+48.42% | 140B | B+ | ||
+67.56% | 131B | - | - | |
-40.22% | 128B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 4062 Stock
- Ratings Ibiden Co.,Ltd.